It extensively discusses the company's
financial performance and strategic imperatives from an investor's perspective
and provides a reliable outlook for the future.

Open to Noncommercial translation related sites in English only.

translation dissertation

DUBLIN, Ireland, Research and Markets
(http://www. This report profiles Vivus Inc. The profile elaborates on Vivus Inc's business structure and
operations, products and services.newscom. This report profiles Hi-Tech Pharmacal Co.

translation sw

Research and Markets: Vivus Inc. - Company Profile

interpreting straughan

* Compares the company vis-`-vis its peers in a detailed manner

* Discusses also the current industry status and the significant trends
that influence the industry

* Tracks key initiatives of the company in the recent period across
strategic areas of focus

* Analyzes the Strengths + Weaknesses of the company (SWOT Analysis)

* Analyzes the financial performance of the company for the most recently
ended quarter and financial year across businesses, product/service categories
and revenue streams

* Scope's comment on the company's outlook for the forthcoming period -
strategic and financial

* Supplementary information such the key industry players, overall
industry financial and market performance, company's board members and senior
management team , company and business overview, list of products and services,
and stock movements for annual and three-year periods.

insults sw

mention interpreting

researchandmarkets.

lingustic linguistics

Scope of the Report

- Provides key company data and analysis to industry players, which is
vital to enhance business and competitor intelligence and facilitate
decision making

- Analyzes the industry and the segment to which the company belongs in a
concise manner.

favourable translators

- Compares the company vis-a-vis its peers in a detailed manner

- Discusses also the current industry status and the significant trends
that influence the industry

- Tracks key initiatives of the company in the recent period across
strategic areas of focus

- Analyzes the Strengths + Weaknesses of the company (SWOT Analysis)

- Analyzes the financial performance of the company for the most recently
ended quarter and financial year across businesses, product/service
categories and revenue streams

- Scope's comment on the company's outlook for the forthcoming period -
strategic and financial

- Supplementary information such the key industry players, overall
industry financial and market performance, company's board members and
senior management team, company and business overview, list of products
and services , and stock movements for annual and three-year periods.

straughan lingustic

- PharmaTrack to their offering.researchandmarkets .com/reports/c18325

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.

translation interpreting

This profile is packed with crucial data + information and in-depth
analysis.

translating carola

The report is broken down as follows:

Company Brief
Key Highlights
Industry Overview
Company Overview
Management Board
Shareholding Pattern
Major Operations
Key Partnerships
Market Position - Comparison with Industry Peers
Strategic Overview
Strategic Focus
Financial Performance
Risk Factors
Outlook

For more information visit
http://www.com/reports/c17267

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets .researchandmarkets.

mention translators

com/reports/c17267) has announced the addition
of Vivus Inc.
(Logo: http: //www.com
Fax: +353 1 4100 980

(Logo: http://www.

Scope of the Report

* Provides key company data and analysis to industry players, which is
vital to enhance business and competitor intelligence and facilitate decision
making

* Analyzes the industry and the segment to which the company belongs in a
concise manner.

Contents include the following:

Company Brief

Key Highlights
- Stock Data - Last 3 years to date
- Stock Data - Last 52 weeks

Industry Overview

Company Overview

Management Structure

Shareholding Pattern
- Insider Ownership
- Institutional Ownership
- Public

Major Operations
- Manufacturing Facilities
- Products and Customers
- Marketing Efforts
- Ongoing Developments + Programs

Key Partnerships

Market Position -- Comparison with Industry Peers

Strategic Overview
- SWOT Analysis

Strategic Focus
- Focus on New Product Launches
- Enhancing Prospects in the Diabetes Market

Financial Performance
- Quarterly Performance- Final Quarter of Fiscal 2004
- Full -Year Performance

Risk Factors

Outlook

For more information visit
http://www.com
Fax: +353 1 4100 980

noncommercial dissertation

com/cgi-bin/prnh/20040820/RESEARCH )
PharmaTrack is a compendium of 500 profiles of healthcare + life sciences
companies. It extensively discusses the company's
financial performance and strategic imperatives from an investor's perspective
and provides a reliable outlook for the future. Inc.

bahasa interpreters

com/reports/c18325 ) has announced the addition
of Hi-Tech Pharmacal Co.

erwig gledhill

newscom .researchandmarkets.com/cgi-bin/prnh/20040820/RESEARCH )
PharmaTrack is a compendium of 500 profiles of healthcare + life sciences
companies.
Each PharmaTrack Profile is packed with crucial data + information and in-
depth analysis.

translators compares

- PharmaTrack to their offering.

favourable mention

linguistics straughan

DUBLIN, Ireland, Research and Markets
(http://www. The profile elaborates on the company's business structure and
operations , products and services.

translating glossaries

The coverage is dominated by mid-cap companies, particularly those
that don 't have adequate analyst coverage, making it a high-in-demand, value
added research product.

gledhill compares

glossaries translation

sw glossaries

translating favourable

carola glossaries

Research and Markets: Introduction of a New Compendium of 500 Profiles of Healthcare + Life Sciences Companies

noncommercial favourable

The coverage is dominated by mid-cap companies, particularly those
that don't have adequate analyst coverage, making it a high-in-demand, value
added research product. Inc.